Tag: Pomerantz LLP

Viaskin Peanut

Private Law Firm to Investigate Claims on Behalf of Investors in...

It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
Vial + Syringe

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

Drugs — sometimes touted as miracle treatments during development — don't necessarily pan out despite the hype.

Multiple Class Action Lawsuits Filed on Behalf of Shareholders Against Mylan

The actions are the result of a $465 million settlement the firm reached with the Justice Department regarding overcharging claims.